France’s research on HIV/AIDS, hepatitis in Vietnam updated
A scientific conference on HIV and hepatitis-related studies of the French National Agency for Research on AIDS (ANRS) in Vietnam opened in Hanoi on June 19.
The health sector has expanded testing activities to detect HIV infected people, especially in key areas, high-risk groups. - Illustrative image (Source: VNA)
Hanoi (VNA) - A scientific conference on HIV and hepatitis-related studies ofthe French NationalAgency for Research on AIDS (ANRS) in Vietnam opened in Hanoi on June 19.
The event attractednearly 200 scientists, medical managers, researchers, and partners from France,Cambodia, European and North American countries operating in the field.
Thetwo-day conference focuses on scientific cooperation in HIV/AIDS research andprevention between the Vietnamese Ministry of Health and the ANRS; HIV/AIDSprevention, care and treatment; viral hepatitis; elimination of hepatitis Ctransmission among drug users; tuberculosis and HIV co-infection; and HIVcontrol in drug users.
Participants were updated on the latest findings and studies on HIV/AIDS of theANRS in Vietnam and other countries, and measures to preventing the spread of HIVvirus worldwide.
Theyheard that the proportion of people living with HIV/AIDS participating in healthinsurance has increased significantly, from 50 percent in October 2016 to about90 percent at present. Many provinces reported the rate of 100 percent ofARV-treated patients with health insurance cards.
In 2019, the health sector has expanded testing activities to detect HIVinfected people, especially in key areas, high-risk groups, in prisons and mountainousareas.
Scientific cooperation in HIV/AIDS research and prevention between the MoH and theANRS started in early 2000 and entered a new stage of development with thesigning of the MOU between the two sides on January 18, 2018.
The cooperation has helped to transfer technology to Vietnam for applying toscientific research and improve capacity of medical staff working in the field,contributing to promoting Vietnam’s international integration in scientificresearch and fine-tuning the quality of care and treatment for HIV-infected patientsin the country.-VNA
Up to 98 percent of the 1,024 HIV carriers in the northern province of Bac Giang are receiving antiretroviral (ARV) drugs covered by health insurance (SHI), heard a medical event in the province on March 15.
The Undetectable=Untransmittable or K=K (Khong phat hien=Khong lay truyen) campaign was launched in Hanoi on May 3 with a training course on communications work for the campaign.
Hanoi has seen improvements in three criteria for HIV control, including the number of people newly diagnosed with HIV, the number of HIV-infected people transferring to AIDS stage, and the number of people who have died of HIV/AIDS over the past decade.
The Ministry of Health’s Department of HIV/AIDS Prevention and Control on June 12 delivered the first free pre-exposure prophylaxis (PrEP) medicine to people with high risk of HIV exposure in Ho Chi Minh City.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.